News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Announces Publication of DUR-928's Mechanism of Action -- DUR-928 is an inhibitor of DNA methyltransferases (DNMTs) regulating expression of genes involved in cell survival, inflammation and lipid biosynthesis -- Mechanism of action supports development of...
DURECT Corporation Announces Fourth Quarter and Full Year 2020 Financial Results and Update of Programs Webcast of Earnings Call Today, March 4th at 4:30 p.m. Eastern Time PR Newswire CUPERTINO, Calif. , March 4, 2021 /PRNewswire/ -- DURECT Corporation (N...
DURECT Corporation to Participate in Three Investor Conferences in March 2021 PR Newswire CUPERTINO, Calif. , March 3, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will partipate in three upcoming investor conferenc...